I-BASE HIV TREATMENT BULLETINImportant note: Information in this article was accurate in October 2003. The state of the art may have changed since the publication date.
Click here to return to I-BASE main menu
DonateNow
Print this Article

South African cabinet rules that public hospitals should provide ARVs

HIV Treatment Bulletin - October 2003
Graham McKerrow, HIV i-Base


The South African government has instructed its health minister, Manto Tshabalala-Msimang, to draw up, within one month, a plan to make antiretroviral therapy available in public hospitals. There have been false dawns and apparent u-turns by the South African government in the past, but this move does seem to bring to an end four years of inactivity by President Thabo Mbeki’s government.

Domestic and international anger has been aroused over the years by Mr Mbeki’s questioning of the causal link between HIV and AIDS and the refusal of his government to provide ARVs. There have been several announcements that official policy had changed – promises that were never fulfilled.

This change of heart appears to be different because it was taken by the full cabinet, arises from a joint report by the health ministry and the treasury, and because it has resulted in an instruction that an operational plan be drawn up within a month.

The Treatment Action Campaign (TAC) issued a statement welcoming the cabinet’s endorsement of the report, which found that between 500,000 and 1,7 million South African lives could be prolonged with ART and that the country could afford to provide the treatment in public hospitals. TAC said: “There is cause for celebration and optimism.”

Shortly before the cabinet’s decision, the TAC learnt that the announcement was imminent and members persuaded Zackie Achmat, one of the organisation’s leading figures, to start treatment. He had refused treatment while the government refused to treat other people.

The announcement was accompanied by other related and significant moves. It was announced that some of the money and expertise for providing the treatment would be supplied by the Bill Clinton Foundation. The Global Fund to Fight AIDS, TB and Malaria announced that a $27 million grant it has been waiting to give to organisations in South Africa for work including ARV treatment – but which was held up by the government – had finally been accepted.

A statement issued by the special cabinet meeting said: “Cabinet decided that the Department of Health should, as matter of urgency, develop a detailed operational plan on an antiretroviral treatment programme. The Department will be assisted in this work by South African experts as well as specialists from the Clinton Foundation AIDS Initiative who have not only offered to contribute to this effort, but have also been of great assistance in commenting on the work done thus far. It is expected that this detailed work would be completed by the end of September 2003.”

The TAC statement said: “This is a critical step to develop a more comprehensive treatment and prevention plan for managing the HIV/AIDS epidemic. Properly implemented, this will restore hope, dignity and life for millions of people in our country, and, hope throughout the continent.

“The TAC National Executive will formally suspend the civil disobedience campaign and reconsider pending litigation early next week. We welcome Cabinet’s bold step today but we also remember the anguish, pain and unnecessary loss of lives over the last four years.”

AIDS leads to 600 deaths in South Africa a day.

The government statement on the special cabinet meeting can be read at http://www.gov.za, and a pdf of the full Report of the Joint Health and Treasury Task Team can be downloaded by (clicking here)

TAC’s response is at: http://www.tac.org.za/newsletter/2003/ns08_08_2003.htm

031010
IB30408-08


©2003. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.